Inari Medical Newsroom

Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)

TipRanksMay 28 06:54 ET

Analysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)

TipRanksMay 2 02:50 ET

Inari Medical Analyst Ratings

BenzingaMay 1 14:02 ET

Bank of America Securities Sticks to Their Buy Rating for Inari Medical (NARI)

TipRanksMay 1 09:10 ET

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)

TipRanksMay 1 07:25 ET

Inari Medical Analyst Ratings

BenzingaMay 1 05:44 ET

Inari Medical Analyst Ratings

BenzingaApr 12 12:02 ET

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

BenzingaApr 12 12:00 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Inari Medical (NARI) and Roivant Sciences (ROIV)

TipRanksApr 3 05:05 ET

Inari Medical Analyst Ratings

BenzingaMar 22 09:11 ET

Needham Reiterates Buy on Inari Medical, Maintains $72 Price Target

BenzingaMar 6 07:46 ET

Inari Medical Analyst Ratings

BenzingaMar 6 07:44 ET

Inari Medical Buy Rating Justified by Industry-Standard Physician Payments and Resilient Sector Trends

TipRanksMar 6 05:35 ET

Piper Sandler Cuts Inari to Neutral; Cites Slowing Growth, DOJ Probe

Seeking AlphaMar 1 16:03 ET

Critical Insights From Inari Medical Analyst Ratings: What You Need To Know

BenzingaFeb 29 11:01 ET

Inari Medical (NARI) Gets a Hold From Truist Financial

TipRanksFeb 29 07:21 ET

Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating

MT NewswiresFeb 29 07:20 ET

Inari Medical: Strong Buy Rating Amidst Long-Term Growth Prospects and Strategic Initiatives

TipRanksFeb 29 06:45 ET

Inari Medical (NARI) Receives a Hold From Truist Financial

TipRanksJan 30 21:25 ET

Needham Starts Inari at Buy, Citing Improving Operating Margins

Seeking AlphaJan 23 16:32 ET